🔗 Permalink

Inventor profile of:

Andreas Wilmen

City:

Koln

Country:

Germany

Published Applications:

Last publication date:

2025-11-27

Top Assignees for applications by Andreas Wilmen

The entities that hold a legal rights for patent applications filed by inventor Wilmen Andreas:

Bayer Intellectual Property GmbH 12 Monheim, Germany
Bayer Aktiengesellschaft 7 Leverkusen, Germany
Bayer Pharma Aktiengesellschaft 6 Berlin, Germany
Bayer Schering Pharma Aktiengesellschaft 3 Berlin, Germany
BAYER HEALTHCARE AG 1 Leverkusen, Germany
Bayer Intellectual Property GmbH 1 Monehim, Germany
Boehringer Ingelheim International GmbH 1 , Germany
BAYER SCHERING PHARMA AKTIENGESELLESCHAFT 1 Berlin, Germany
ARONORA INC. 1 Portland, OR United States
Oklahoma Medical Research Foundation 1 Oklahoma City, OK United States

Recent patent applications by Wilmen Andreas

Andreas Wilmen from Koln, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27

US20250361282A1

Chemistry; metallurgy

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#2 | 2025-07-24

US20250236654A1

Chemistry; metallurgy

C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#3 | 2024-05-23

US20240166766A1

Chemistry; metallurgy

Anti-A2AP antibodies and uses thereof

#4 | 2024-02-01

US20240034810A1

Chemistry; metallurgy

ANTI-A2AP ANTIBODIES AND USES THEREOF

#5 | 2024-01-11

US20240010750A1

Chemistry; metallurgy

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

#6 | 2021-12-23

US20210395390A1

Chemistry; metallurgy

REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-FXIA ANTIBODIES

#7 | 2021-05-20

US20210147504A1

Chemistry; metallurgy

BRAIN NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#8 | 2021-05-13

US20210139555A1

Chemistry; metallurgy

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#9 | 2021-03-18

US20210079056A1

Chemistry; metallurgy

C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#10 | 2019-09-19

US20190284300A1

Chemistry; metallurgy

Antibodies capable of binding to the coagulation factor XIa and uses thereof

#11 | 2019-07-25

US20190225705A1

Chemistry; metallurgy

Antibodies against factor XI and uses thereof

#12 | 2018-11-15

US20180326053A1

Human necessities

Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof

#13 | 2018-04-26

US20180112009A1

Chemistry; metallurgy

Antibodies capable of binding to the coagulation factor XIa and uses thereof

#14 | 2018-02-22

US20180051093A1

Chemistry; metallurgy

Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof

#15 | 2016-11-03

US20160319029A1

Chemistry; metallurgy

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

#16 | 2016-01-14

US20160009776A1

Chemistry; metallurgy

PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF

#17 | 2015-11-19

US20150329613A1

Chemistry; metallurgy

FUSION POLYPEPTIDES AND USES THEREOF

#18 | 2015-04-09

US20150099298A1

Chemistry; metallurgy

Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof

#19 | 2014-07-03

US20140187491A1

Chemistry; metallurgy

Relaxin fusion polypeptides and uses thereof

#20 | 2014-05-29

US20140148390A1

Chemistry; metallurgy

FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF

#21 | 2014-05-22

US20140141003A1

Chemistry; metallurgy

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

#22 | 2013-11-07

US20130296343A1

Chemistry; metallurgy

SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES

#23 | 2013-10-17

US20130272968A1

Human necessities

Neutralizing prolactin receptor antibodies and their therapeutic use

#24 | 2013-10-03

US20130261115A1

Chemistry; metallurgy

Imidazo-, pyrazolopyrazines and imidazotriazines and their use

#25 | 2013-05-23

US20130129739A1

Chemistry; metallurgy

Neutralizing prolactin receptor antibodies and their therapeutic use

#26 | 2013-02-14

US20130040946A1

Chemistry; metallurgy

Substituted imidazopyrimidines and triazolopyrimidines

#27 | 2012-12-20

US20120321632A1

Human necessities

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE

#28 | 2011-08-04

US20110190316A1

Chemistry; metallurgy

Substituted pyridines, and use thereof as GSK3 inhibitors

#29 | 2011-06-16

US20110144131A1

Chemistry; metallurgy

Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines

#30 | 2011-03-03

US20110053929A1

Chemistry; metallurgy

Imidazo-, pyrazolopyrazines and imidazotriazines and their use

#31 | 2010-05-06

US20100113441A1

Chemistry; metallurgy

Substituted imidazopyrimidines and triazolopyrimidines

#32 | 2010-02-11

US20100035882A1

Human necessities

INHIBITION OF PDE2A

#33 | 2009-10-15

US20090258877A1

Chemistry; metallurgy

TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE

InventorID:

91714 ⎘